Alyeska Investment Group

Alyeska Investment Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Alyeska Investment Group’s Portfolio RETA Stock Details RETA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$5.2M	Buy
2018 Q2	–	Sell
2018 Q1	$3.12M	Sell
2017 Q4	$5.82M	Buy
2017 Q3	$2.83M	Buy